| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A8K901 | cDNA FLJ77190, highly similar to Homo sapiens ubiquitin protein ligase E3 component n-recognin 1 (UBR1), mRNA; Fragment; | NULL | NULL | 1013 | human |
| A8MXX7 | Probable protein phosphatase 1N; | PPM1N; | NULL | 137 | human |
| A8K212 | cDNA FLJ76230, highly similar to Homo sapiens killer cell lectin-like receptor subfamily A, member 1 (KLRA1), mRNA; | NULL | NULL | 215 | human |
| A9Z198 | MHC class I antigen; Fragment; | HLA-B; | NULL | 181 | human |
| E5RFH0 | Eukaryotic translation initiation factor 3 subunit H; Fragment; | EIF3H; | NULL | 170 | human |
| B2KKJ9 | C-C motif chemokine receptor 5 V130I variant; | CCR5; | NULL | 352 | human |
| B2NI05 | Major prion protein; | PRNP; | NULL | 230 | human |
| Q8HWG1 | MHC class I antigen; Fragment; | HLA-Cw; | NULL | 67 | human |
| B2R658 | cDNA, FLJ92802, highly similar to Homo sapiens decay accelerating factor for complement (CD55, Cromerblood group system) (DAF), mRNA; | NULL | NULL | 381 | human |
| B2RTS4 | Centrosomal protein 170kDa; | CEP170; | NULL | 1486 | human |
| E5RFJ0 | Dedicator of cytokinesis protein 2; | DOCK2; | NULL | 1031 | human |
| B2RAJ9 | cDNA, FLJ94962; | NULL | NULL | 915 | human |
| B2R5Q5 | cDNA, FLJ92569, highly similar to Homo sapiens interferon-induced protein 44-like (IFI44L), mRNA; | NULL | NULL | 413 | human |
| B2R4K7 | 60S ribosomal protein L6; | NULL | NULL | 288 | human |
| B2RBM7 | cDNA, FLJ95595, highly similar to Homo sapiens proteasome (prosome, macropain) 26S subunit, non-ATPase, 13 (PSMD13), mRNA; | NULL | NULL | 376 | human |
| Q19UG5 | Coagulation factor IX; Fragment; | F9; | NULL | 182 | human |
| A8KA77 | cDNA FLJ78669, highly similar to Homo sapiens tetratricopeptide repeat domain 21B (TTC21B), mRNA; | NULL | NP_079029.3; | 1316 | human |
| B2R657 | Annexin; | NULL | NP_004025.1; | 488 | human |
| B3KM55 | cDNA FLJ10336 fis, clone NT2RM2000691, highly similar to Homo sapiens ARP3 actin-related protein 3 homolog B (yeast) (ACTR3B), mRNA; | NULL | NULL | 126 | human |
| B3KS92 | cDNA FLJ35783 fis, clone TESTI2005568, highly similar to Homo sapiens cancer susceptibility candidate 1 (CASC1), mRNA; | NULL | NULL | 485 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |